Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lux Capital
Biotech
Eikon remains in megaround mode with $350M series D
Eikon is no stranger to megarounds, and the cancer-focused biotech has continued this trend with $350 million to fuel its clinical trials.
James Waldron
Feb 26, 2025 9:40am
Enveda envisions clinical wins with $130M series C raise
Nov 21, 2024 10:55am
Mendaera grabs $73M for handheld, needle-based robotics system
Sep 27, 2024 11:30am
A new dimension: Biotech VC unveils with $350M
Jan 25, 2023 11:31am
Amgen-partnered Plexium snags $102M for protein degraders
Feb 23, 2022 8:00am
Leaps by Bayer leads $40M Gandeeva funding
Jan 31, 2022 8:00am
